MILAN, July 01, 2022--Newron extends Senior Management team and strengthens its commitment to ESG by appointing Filippo Moriggi as Vice President of Operations.
MILAN, Italy, June 07, 2022--Newron presents encouraging interim results for evenamide in patients with Treatment-Resistant Schizophrenia (TRS). Conference call today at 9 AM ET.
MILAN, March 15, 2022--Newron Pharmaceuticals (SIX: NWRN, XETRA: NP5) announces 2021 financial results and provides outlook for 2022. Conference call today at 10:00 AM EDT.